«HYPERLIPOPROTEINEMIA»に関連する英語の本
以下の図書目録から
hyperlipoproteinemiaの使いかたを見つけましょう。
hyperlipoproteinemiaに関する本と英語文献で使われた文脈を提供するための簡単な抜粋文。
1
Manual of Nutritional Therapeutics
This condition is also called remnant hyperlipoproteinemia,
dysbetalipoproteinemia, or broad- beta disease because the ... Type III
hyperlipoproteinemia is relatively uncommon, with a prevalence between 1 in
10,000 and 1 in 20,000 (116).
I Hyperlipoproteinemia Hyperlipoproteinemia is an inherited disorder marked by
increased plasma concentrations of one or more lipoproteins.
Hyperlipoproteinemia may also occur secondary to other conditions, such as
diabetes, pancreatitis, ...
Lippincott Williams & Wilkins, 2008
3
Modern Nutrition in Health and Disease
Affected patients have severe chylomicronemia similar to those with LPL
deficiency. They, too, have the pattern of tvpe I hyperlipoproteinemia. Type V
Hyperlipoproteinemia Tt/pe V hyperlipoproteinemia is characterized by high
serum levels of ...
Maurice Edward Shils, Moshe Shike, 2006
4
Differential Diagnosis by Laboratory Medicine: A Quick ...
G.GHb, cholesterol, chylomicrons, IDL-C, uric acid, LDL-C, pre-beta-lipo- proteins
, TAG, VLDL-C i apolipoprotein - (A-I, E-III, E-IV), HDL-C, LDL-C • Synovia/ Fluid T
WBC, PMN hyperlipoproteinemia IV T apolipoprotein - (B-48, B-ioo, C-I, C-II, ...
Vincent Marks, Dusan Mesko, 2002
5
Molecular Genetics & Gene Therapy of Cardiovascular Diseases
The next crucial discovery establishing the molecular basis of type III
hyperlipoproteinemia was that apo E2 was defective in binding to the LDL
receptor (78). In contrast, both apo E3 and apo E4 bound very well (78,79). In
addition, it was ...
6
Gout: Basic Science and Clinical Practice
... and binding to lipoprotein receptors. Mutant apo-E in type III
hyperlipoproteinemia alters binding to lipoprotein receptors [985–987]. The most
common mutant form of apo-E is apo-E-2, and this mutant results in type III
hyperlipoproteinemia ...
David S. Newcombe, Dwight R. Robinson, 2012
7
Biochemical Basis of Inherited Human Disease
concentration and fractional catabolic rate is observed in patients with type II
hyperlipoproteinemia, but in this case the entire range of LDL concentrations is
shifted to a higher level (Fig. 5). Studies of '"I-LDL metabolism in patients zvith
type II ...
8
Nutritional Support Handbook
Immunoreactive insulin, glucose tolerance, and carbohydrate inducibility in types
II, III, IV, and V hyperlipoproteinemia. Diabetes 18:739-47. Hatch, F. T. 1974.
Interactions between nutrition and heredity in coronary heart disease. American ...
9
Dorland's Illustrated Medical Dictionary
See table of hyperlipoproteinemias. essential familial h. a term used to describe
an inherited disorder causing a type I hyperlipoproteinemia phenotype or the
phenotype itself. exogenous h. elevated plasma levels of lipoproteins derived
from ...
10
Dorland's Illustrated Medical Dictionary32: Dorland's ...
See table of hyperlipoproteinemias. essential familial h. a term used to describe
an inherited disorder causing a type I hyperlipoproteinemia phenotype or the
phenotype itself. exogenous h. elevated plasma levels of lipoproteins derived
from ...
用語«HYPERLIPOPROTEINEMIA»を含むニュース項目
国内外の報道機関が語った内容や、次のニュース項目の文脈から
hyperlipoproteinemiaという用語がどのように使われているかを調べてみましょう。
Research and Markets: Familial Hypercholesterolemia (Type II …
Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) - Pipeline Insights provides the in-depth analysis of the pipeline assets across ... «Business Wire, 7月 15»
Research and Markets: Familial Chylomicronemia (Type I …
Familial Chylomicronemia (Type I Hyperlipoproteinemia) - Pipeline Insights provides the in-depth analysis of the pipeline assets across the ... «Business Wire, 7月 15»
Akcea Therapeutics Receives Orphan Drug Designation from the …
FCS may also be called familial chylomicronemia, Frederickson Type I hyperlipoproteinemia, familial lipoprotein lipase deficiency (LPLD), ... «PR Newswire, 7月 15»
Hypercholesterolemia Treatment Market – Global Industry Analysis …
Hypercholesterolemia, also termed as dyslipidemia, is a form of hyperlipidemia and hyperlipoproteinemia in the body. Presence of low-density ... «Medgadget.com, 6月 15»
A formal concept analysis and semantic query expansion …
... "Sitosterolemia for hypercholesterolemia" for hypercholesterolemia) and potential (e.g., "h/o: raised blood, familial hyperlipoproteinemia", "fh: ... «BMC Blogs Network, 5月 15»
CymaBay Therapeutics' (CBAY) CEO Hal Van Wart on Q1 2015 …
SHTG is a condition in which patients with Fredrickson types I or V hyperlipoproteinemia have markedly elevated levels of triglycerides, ... «Seeking Alpha, 5月 15»
CymaBay Therapeutics Announces the Initiation of a Phase 2 Study …
MBX-8025 has also received orphan designation for Fredrickson types I and V hyperlipoproteinemia. About MBX-8025. MBX-8025 is a potent ... «MarketWatch, 4月 15»
CymaBay Therapeutics Announces U.S. Orphan Drug Designation …
... drug designation for MBX-8025 to treat patients with hyperlipoproteinemia types I or V (Fredrickson classification). MBX-8025 is a potent and ... «Marketwired, 4月 15»
A tribute to Peter O. Kwiterovich Jr., MD
In 1973, Kwiterovich wrote a seminal paper in The Lancet, titled “Neonatal Diagnosis of Familial Type-II Hyperlipoproteinemia,” which was cited ... «Healio, 9月 14»
Stroke Rounds: APOE Tied to Warfarin Brain Bleeds
APOE is a protein coding gene and its alleles have been linked to several human diseases including hyperlipoproteinemia, Alzheimer's ... «MedPage Today, 8月 14»
